May Measure Month 2022 in Italy: A Focus on Fixed-dose Combination, Therapeutic Adherence, and Medical Inertia in a Nationwide Survey.
Blood pressure
Hypertension
Prevention campaigns
Therapeutic inertia
Journal
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension
ISSN: 1179-1985
Titre abrégé: High Blood Press Cardiovasc Prev
Pays: New Zealand
ID NLM: 9421087
Informations de publication
Date de publication:
03 Jun 2024
03 Jun 2024
Historique:
received:
29
02
2024
accepted:
04
04
2024
medline:
3
6
2024
pubmed:
3
6
2024
entrez:
2
6
2024
Statut:
aheadofprint
Résumé
Hypertension is the main risk factor for cardiovascular diseases (CVD). Notably, only about half of hypertensive patients manage to achieve the recommended blood pressure (BP) control. Main reasons for the persistence of uncontrolled BP during treatment are lack of compliance on the patients' side, and therapeutic inertia on physicians' side. During the global BP screening campaign "May Measure Month" (MMM) (May 1st to July 31st, 2022), a nationwide, cross-sectional, opportunistic study endorsed by the Italian Society of Hypertension was conducted on volunteer adults ≥ 18 years to raise awareness of the health issues surrounding high BP. A questionnaire on demographic/clinical features and questions on the use of fixed-dose single-pills for the treatment of hypertension was administered. BP was measured with standard procedures. A total of 1612 participants (mean age 60.0±15.41 years; 44.7% women) were enrolled. Their mean BP was 128.5±18.1/77.1±10.4 mmHg. About half of participants were sedentary, or overweight/obese, or hypertensive. 55.5% individuals with complete BP assessment had uncontrolled hypertension. Most were not on a fixed-dose combination of antihypertensive drugs and did not regularly measure BP at home. Self-reported adherence to BP medications was similar between individuals with controlled and uncontrolled BP (95% vs 95.5%). This survey identified a remarkable degree of therapeutic inertia and poor patients' involvement in the therapeutic process and its monitoring in the examined population, underlining the importance of prevention campaigns to identify areas of unsatisfactory management of hypertension, to increase risk factors' awareness in the population with the final purpose of reducing cardiovascular risk.
Identifiants
pubmed: 38825650
doi: 10.1007/s40292-024-00642-4
pii: 10.1007/s40292-024-00642-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, Gregg EW, Bennett JE, Solomon B, Singleton RK, Sophiea MK, Iurilli ML, Lhoste VP, Cowan MJ, Savin S, Woodward M, Balanova Y, Cifkova R, Damasceno A, Ezzati M. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–80. https://doi.org/10.1016/S0140-6736(21)01330-1 .
doi: 10.1016/S0140-6736(21)01330-1
WHO Global report on hypertension. https://www.who.int/teams/noncommunicable-diseases/hypertension-report . Accessed 30 Jan 2024
Borghi C, Agnoletti D, Cicero AFG, Lurbe E, Virdis A. Uric ACID and hypertension: a review of evidence and future perspectives for the management of cardiovascular risk. Hypertension. 2022;79(9):1927–36. https://doi.org/10.1161/HYPERTENSIONAHA.122.17956 .
doi: 10.1161/HYPERTENSIONAHA.122.17956
pubmed: 35658505
Honigberg MC, Zekavat SM, Niroula A, Griffin GK, Bick AG, Pirruccello JP, Nakao T, Whitsel EA, Farland LV, Laurie C, Kooperberg C, Manson JE, Gabriel S, Libby P, Reiner AP, Ebert BL, Natarajan P. Premature menopause, clonal hematopoiesis, and coronary artery disease in postmenopausal women. Circulation. 2021;143(5):410–23. https://doi.org/10.1161/CIRCULATIONAHA.120.051775 .
doi: 10.1161/CIRCULATIONAHA.120.051775
pubmed: 33161765
Surma S, Romańczyk M, Witalińska-Łabuzek J, Czerniuk MR, Łabuzek K, Filipiak KJ. Periodontitis, blood pressure, and the risk and control of arterial hypertension: epidemiological, clinical, and pathophysiological aspects—review of the literature and clinical trials. Curr Hypertens Rep. 2021. https://doi.org/10.1007/s11906-021-01140-x .
doi: 10.1007/s11906-021-01140-x
pubmed: 34370111
pmcid: 8352830
Del Pinto R, Landi L, Grassi G, Sforza NM, Cairo F, Citterio F, Paolantoni G, D’Aiuto F, Ferri C, Monaco A, Pietropaoli D. Hypertension and periodontitis: a joint report by the Italian Society of Hypertension (SIIA) and the Italian Society of Periodontology and Implantology (SIdP). High Blood Press Cardiovasc Prev. 2021. https://doi.org/10.1007/s40292-021-00466-6 .
doi: 10.1007/s40292-021-00466-6
pubmed: 34562228
pmcid: 8484186
Del Pinto R, Desideri G, Ferri C, Agabiti Rosei E. Real-world antihypertensive treatment patterns, treatment adherence, and blood pressure control in the elderly: an Italian awareness-raising campaign on hypertension by Senior Italia FederAnziani, the Italian Society of Hypertension and the Italian Federation of General Practitioners. High Blood Press Cardiovasc Prev. 2021;28(5):457–66. https://doi.org/10.1007/s40292-021-00465-7 .
doi: 10.1007/s40292-021-00465-7
pubmed: 34185255
pmcid: 8484252
Massimo Volpe con la collaborazione di Giovanna Gallo. (2017) Aderenza e continuità terapeutica nell’ipertensione arteriosa: il problema e le possibili soluzioni. SPECIALITIES CORNER: Ipertensione Arteriosa. Rivista Società Italiana di Medicina Generale N.5 VOL.24 2017
Del Pinto R, Pagliacci S, de Feo M, Grassi D, Ferri C. Prevalence of hypertension and associated cardiovascular risk factors among pharmacies customers: an Italian nationwide epidemiological survey. Eur J Prev Cardiol. 2020;27(11):1228–30. https://doi.org/10.1177/2047487319851301 .
doi: 10.1177/2047487319851301
pubmed: 31116573
Williams B, Mancia G, Spiering W, AgabitiRosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Brady A. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104. https://doi.org/10.1093/eurheartj/ehy339 .
doi: 10.1093/eurheartj/ehy339
pubmed: 30165516
Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida J-M, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Williams B. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–337. https://doi.org/10.1093/eurheartj/ehab484 .
doi: 10.1093/eurheartj/ehab484
pubmed: 34458905
World Medical Association Declaration of Helsinki. JAMA. 2013;310(20), 2191. https://doi.org/10.1001/jama.2013.281053 .
Article 89 EU GDPR "Safeguards and derogations relating to processing for archiving purposes in the public interest, scientific or historical research purposes or statistical purposes". https://www.privacy-regulation.eu/en/article-89-safeguards-and-derogations-relating-to-processing-for-archiving-purposes-the-public-interest-scientific-or-hi-GDPR.htm . Accessed 30 Jan 2024
Dixon DL, Sharma G, Sandesara PB, Yang E, Braun LT, Mensah GA, Sperling LS, Deedwania PC, Virani SS. Therapeutic inertia in cardiovascular disease prevention. J Am Coll Cardiol. 2019;74(13):1728–31. https://doi.org/10.1016/j.jacc.2019.08.014 .
doi: 10.1016/j.jacc.2019.08.014
pubmed: 31558257
Ali DH, Kiliç B, Hart HE, Bots ML, Biermans MCJ, Spiering W, Rutten FH, Hollander M. Therapeutic inertia in the management of hypertension in primary care. J Hypertens. 2021;39(6):1238–45. https://doi.org/10.1097/HJH.0000000000002783 .
doi: 10.1097/HJH.0000000000002783
pubmed: 33560056
Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the healthy people 2010 blood pressure control goals. Hypertension. 2006;47(3):345–51. https://doi.org/10.1161/01.HYP.0000200702.76436.4b .
doi: 10.1161/01.HYP.0000200702.76436.4b
pubmed: 16432045
Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Jordan LC, Khan SS, Kissela BM, Knutson KL, Virani SS. Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation. 2019. https://doi.org/10.1161/CIR.0000000000000659 .
doi: 10.1161/CIR.0000000000000659
pubmed: 31744331
pmcid: 7043236
Redón J, Coca A, Lázaro P, Aguilar MD, Cabañas M, Gil N, Sánchez-Zamorano MÁ, Aranda P. Factors associated with therapeutic inertia in hypertension: validation of a predictive model. J Hypertens. 2010;28(8):1770–7. https://doi.org/10.1097/HJH.0b013e32833b4953 .
doi: 10.1097/HJH.0b013e32833b4953
pubmed: 20531224
Gil-Guillén V, Orozco-Beltrán D, Pérez RP, Alfonso JL, Redón J, Pertusa-Martínez S, Navarro J, Cea-Calvo L, Quirce-Andrés F, Merino-Sánchez J, Carratalá C, Martín-Moreno JM. Clinical inertia in diagnosis and treatment of hypertension in primary care: quantification and associated factors. Blood Press. 2010;19(1):3–10. https://doi.org/10.3109/08037050903350762 .
doi: 10.3109/08037050903350762
pubmed: 19929287
Augustin A, Coutts L, Zanisi L, Wierzbicki AS, Shankar F, Chowienczyk PJ, Floyd CN. Impact of therapeutic inertia on long-term blood pressure control. Hypertension. 2021;77(4):1350–9. https://doi.org/10.1161/HYPERTENSIONAHA.120.15866 .
doi: 10.1161/HYPERTENSIONAHA.120.15866
pubmed: 33641362
Gupta P, Patel P, Horne R, Buchanan H, Williams B, Tomaszewski M. How to screen for non-adherence to antihypertensive therapy. Curr Hypertens Rep. 2016;18(12):89. https://doi.org/10.1007/s11906-016-0697-7 .
doi: 10.1007/s11906-016-0697-7
pubmed: 27889904
pmcid: 5124437
Bahiru E, de Cates AN, Farr MR, Jarvis MC, Palla M, Rees K, Ebrahim S, Huffman MD. Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases. Cochrane Database Syst Rev. 2017. https://doi.org/10.1002/14651858.CD009868.pub3 .
doi: 10.1002/14651858.CD009868.pub3
pubmed: 28263370
pmcid: 6464321
Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents. Hypertension. 2010;55(2):399–407. https://doi.org/10.1161/HYPERTENSIONAHA.109.139816 .
doi: 10.1161/HYPERTENSIONAHA.109.139816
pubmed: 20026768
Sherrill B, Halpern M, Khan S, Zhang J, Panjabi S. Single-pill vs free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherence. J Clin Hypertens. 2011;13(12):898–909. https://doi.org/10.1111/j.1751-7176.2011.00550.x .
doi: 10.1111/j.1751-7176.2011.00550.x
Parati G, Kjeldsen S, Coca A, Cushman WC, Wang J. Adherence to single-pill versus free-equivalent combination therapy in hypertension: a systematic review and meta-analysis hypertension. Am Heart Assoc. 2021;77(2):692–705. https://doi.org/10.1161/HYPERTENSIONAHA.120.15781 .
doi: 10.1161/HYPERTENSIONAHA.120.15781
Charchar FJ, Prestes PR, Mills C, Ching SM, Neupane D, Marques FZ, Sharman JE, Vogt L, Burrell LM, Korostovtseva L, Zec M, Patil M, Schultz MG, Wallen MP, Renna NF, Islam SMS, Hiremath S, Gyeltshen T, Chia Y-C, Tomaszewski M. Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension. J Hypertens. 2024;42(1):23–49. https://doi.org/10.1097/HJH.0000000000003563 .
doi: 10.1097/HJH.0000000000003563
pubmed: 37712135
Del Pinto R, Landi L, Grassi G, Sforza NM, Cairo F, Citterio F, Paolantoni G, D’Aiuto F, Ferri C, Monaco A, Pietropaoli D. Hypertension and periodontitis: a joint report by the Italian Society of Hypertension (SIIA) and the Italian Society of Periodontology and Implantology (SIdP). High Blood Press Cardiovasc Prev. 2021;28(5):427–38. https://doi.org/10.1007/s40292-021-00466-6 .
doi: 10.1007/s40292-021-00466-6
pubmed: 34562228
pmcid: 8484186
Bitencourt FV, Nascimento GG, Costa SA, Andersen A, Sandbæk A, Leite FRM. Co-occurrence of periodontitis and diabetes-related complications. J Dent Res. 2023;102(10):1088–97. https://doi.org/10.1177/00220345231179897 .
doi: 10.1177/00220345231179897
pubmed: 37448314
Del Pinto R, Viazzi F, Pontremoli R, Ferri C, Carubbi F, Russo E. The URRAH study. Panminer Med. 2021. https://doi.org/10.2373/S0031-0808.21.04357-3 .
doi: 10.2373/S0031-0808.21.04357-3
De Feo M, del Pinto R, Pagliacci S, Grassi D, Ferri C. Real-world hypertension prevalence, awareness, treatment, and control in adult diabetic individuals: an Italian Nationwide Epidemiological Survey. High Blood Press Cardiovasc Prev. 2021;28(3):301–7. https://doi.org/10.1007/s40292-021-00449-7 .
doi: 10.1007/s40292-021-00449-7
pubmed: 33835433
pmcid: 8087541